Arkolith/Insider Trading/VYGR/Form 4

Sandrock Alfred

President and CEO, DirectorVoyager Therapeutics, Inc. (VYGR) · full profile →Form 4 · filed Feb 24, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$50K
Net Open-Market Flow
-$50K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 21, 2025Grant(A)145K—$0442K
Feb 20, 2025Sell(S)12K$4.24$50K297K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 21, 2025Grant(A)290K—$0290K

Transaction Codes

A
Grant / award
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-016520) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML